Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities

Leukemia

Volumn 13, Issue 11, 1999, Pages 1713-1720

  Mathew, S ^a   Behm, F G ^a   Dalton, J ^a   Raimondi, S C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cytogenetics; FISH; MLL gene rearrangements; Pediatric acute leukemias; Southern blotting

Indexed keywords

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SCREENING TEST; SOUTHERN BLOTTING;

EID: 0032697175     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401512     Document Type: Article

References (74)

1. Ziemin-Van der Poel S, McCabe NR, Gill HJ, Espinosa R, Patel Y, Harden A, Rubinelli P, Smith SD, Le Beau MM, Rowley JD, Diaz MO. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991; 86: 10735-10739.
2. Cimino G, Moir DT, Canaani O, Williams K, Crist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM, Canaani E. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23) and t(11;19)(q23;p13) chromosome translocation. Cancer Res 1991; 51: 6712-6714.
3. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992; 71: 701-709.
4. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homologue of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992; 71: 691-700.
5. Young BD. Cytogenetic and molecular analysis of chromosome 11q23 abnormalities in leukemia. Bailliere's Clin Haematol 1992; 5: 881-895.
6. Mitelman F, Kaneko Y, Berger R. Report of the committee on chromosome changes in neoplasia. Genome Priority Rep 1993; 1: 700-726.
7. Le Coniat M, Romana SP, Bernard O, Flexor MA, Hillion J, Cherif D, Berger R. A novel translocation t(9;11)(p22;q23) involving the HRX gene in an acute monocytic leukemia. CR Acad Sci 1993; 316: 692-697.
8. Jani Sait SN, Raimondi SC, Look AT, Gill HJ, Thirman M, Diaz MO, Shows TB. A t(11;12) 11q23 leukemic breakpoint that disrupts the MLL gene. Gene Chromos Cancer 1993; 7: 28-31.
9. Corral J, Forster A, Thompson S, Lampert F, Kaneko Y, Slater R, Kroes WG, Van der Schoot CE, Ludwig W-D, Karpas A, Pocock C, Cotter F, Rabbitts TH. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 1993; 90: 8538-8542.
10. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, LeBeau MM, Diaz MO, Rowley JD. Rearrangement of the MLL gene in acute lymphoblastic and myeloid leukemias with 11q23 chromosomal translocations. New Engl J Med 1993; 329: 909-914.
11. Harrison CJ, Cuneo A, Clark R, Johansson B, Lafage-Pochitaloff M, Mugneret F, Moorman AV, Secker-Walker LM. Ten novel 11q23 chromosomal partner sites. Leukemia 1998; 12: 811-822.
12. Mitelman F (ed.). Catalog of Chromosome Aberrations in Cancer. Wiley-Liss: New York, 1997.
13. Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H, Huebner K, Gale RP, Nowell PC, Kuriyama K, Miyazaki Y, Croce CM, Canaani E. Cloning of the ALL-1 fusion partner, AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 1993; 53: 5624-5628.
14. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lane B, Crist WM, Nowell PC, Croce CM. Genes on chromosome 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci USA 1993; 90: 4631-4635.
15. Bernard OA, Mauchauffe M, Mecucci C, Van den Berghe H, Berger R. A novel gene AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogene 1994; 9: 1039-1045.
16. Rubnitz JE, Morrissey J, Savage PA, Cleary ML. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994; 84: 1747-1752.
17. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994; 91: 12110-12114.
18. Parry P, Djabali M, Bower M, Khristich J, Waterman M, Gibbons B, Young BD, Evans G. Structure and expression of the human trithorax-like gene 1 involved in acute leukemias. Proc Natl Acad Sci USA 1993; 90: 4738-4742.
19. Tse W, Zhu W, Chen HS, Cohen A. Novel gene, AF1q, fused to MLL in t(1;11)(q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 1995; 85: 650-656.
20. Chaplin T, Ayton P, Bernard OA, Saha V, Valle VD, Hillion J, Gregorini A, Lillington D, Berger R, Young BD. A novel class of zinc tinger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood 1995; 85: 1435-1441.
21. Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA. AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 1997; 90: 3714-3719.
22. So CW, Caldas C, Liu M-M, Chen S-J, Huang Q-H, Gu L-J, Sham MH, Wiedemann LM, Chan LC. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc Natl Acad Sci USA 1997; 94: 2563-2568.
23. Sobulo OM, Borrow J, Tornek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 1997; 94: 8732-8737.
24. Taki T, Sako M, Tsuchida M, Hayashi Y. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 1997; 89: 3945-3950.
25. Megonigal MD, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM, Lerou PH, Moulton T, Budarf ML, Felix CA. t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci USA 1998; 95: 6413-6418.
26. Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD, Croce CM. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994; 91: 6236-6239.
27. Schichman SA, Caligiuri MA, Strout MP, Carter SL, Gu Y, Canaani E, Bloomfield CD, Croce CM. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res 1994; 54: 4277-4280.
28. Downing JR, Head DR, Raimondi SC, Carroll AJ, Curcio-Brint AM, Motroni TA, Hulshof MG, Pullen DJ, Domer PH. The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23) containing acute lymphoblastic leukemia. Blood 1994; 83: 330-335.
29. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui C-H. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996; 7: 2870-2877.
30. Rubnitz JE, Behm FG, Pui C-H, Evans WE, Relling MV, Raimondi SC, Harrison PL, Sandlund JT, Ribeiro RC, Grosveld G, Downing JR. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia 1997; 11: 1201-1206.
31. Kaneko Y, Shikano T, Maseki N, Sakurai M, Takeda T, Hiyoshi Y, Mimaya JIR, Fujimoto T. Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia 1988; 2: 672-676.
32. Arthur DC, Bloomfield CD, Lindquist LL, Nesbit MEJ. Translocation 4;11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significance. Blood 1982; 59: 96-99.
33. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 70: 2237-2251.
34. Raimondi SC, Frestedt JL, Pui CH, Downing JR, Head HR, Kersey JH, Behm FG. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features. Blood 1995; 86: 1881-1886.
35. Raimondi SC, Ravindranath Y, Chang M, Behm FG, Weinstein HJ, Carroll A. EFS does not differ significantly among 11q23 subgroups in childhood AML: Pediatric Oncology Group study 8821. Blood 1998; 92: A1984.
36. Chen C-S, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH. Molecular rearrangements on chromosome 11q23 predominate in infant ALL and are associated with specific biologic variables and poor outcome. Blood 1993; 81: 2386-2393.
37. Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, Steinherz PG, Zeltzer P, Hammond D, Reaman GH. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Children's Cancer Group. Blood 1994; 83: 2274-2284.
38. Greaves MF. Infant leukemia biology, aetiology and treatment. Leukemia 1996; 10: 372-377.
39. Behm FG, Carroll A, Shuster J, Camitta B, Link M, Lauer S, Land V, Steuber P, Crist W, Pullen J. MLL rearrangement predicts a high risk of failure in children 1 year of age or older with precursor-B ALL. A Pediatric Oncology Group study. Proc Ann Meet Am Assoc Cancer Res 1996; 37: A1271.
40. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro J Jr, Santana VM, Behm F, Dahl G, Williams D, Prognostic importance of cytogenetic subgroups in de novo acute pediatric non-lymphocytic leukemia. J Clin Oncol 1990; 8: 75-83.
41. Martinez-Climent JA, Espinosa R III, Thirman MJ, Le Beau MM, Rowley JD. Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival. J Pediafr Hematol Oncol 1995; 17: 277-283.
42. Sorensen PHB, Chen C-S, Smith FO, Arthur DC, Domer PH, Bernstein ID, Korsmeyer SJ, Hammond GH, Kersey JH. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 1994; 93: 429-437.
43. Behm FG, Shurtleff SA, Raimondi SC, Ribeiro RC, Jayawardene DA, Krance R, Head DR, Mirro J, Srivastava DK, Downing JR. A retrospective molecular study of the frequency of AML/ETO, CBFB/MYH11, PML/RARA and rearrangement of MLL in childhood de novo AML and comparison with survival. Blood 1997; 90: 63A.
44. Cimino G, Lo Coco F, Biondi A, Elia L, Luciano A, Croce CM, Masera G, Mandelli F, Canaani E. ALL-1 gene at 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993; 82: 544-546.
45. Kearney L, Bower M, Gibbons B, Das S, Chaplin T, Nacheva E, Chessells JM, Reeves B, Riley JH, Lister TA, Young BD. Chromosome 11q23 translocations in both infant and adult acute leukemias are detected by in situ hybridization with a yeast artificial chromosome. Blood 1992; 80: 1659-1665.
46. Kobayashi H, Espinosa R III, Thirman MJ, Fernald AA, Shannon K, Diaz MO, Le Beau MM, Rowley JD. Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization. Genes Chromos Cancer 1993; 7: 204-208.
47. Martinez-Climent JA, Thirman MJ, Espinosa R III, Le Beau MM, Rowley JD. Detection of 11q23/MLL rearrangements in infant leukemia with fluorescence in situ hybridization and molecular analysis. Leukemia 1995; 9: 1299-1304.
48. Yamamoto K, Seto M, Iida S, Komatsu H, Kamada N, Kojima S, Kodera Y, Nakazawa S, Saito H, Takahashi T, Ueda R. A reverse transcriptase polymerase chain reaction detects heterogeneous chimeric mRNA in leukemias with 11q23 abnormalities. Blood 1994; 83: 2912-2921.
49. Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C, Leboeuf D, Bastard C, Picard F, Veil-Buzyn A, Flandrin G, Bernard O, Macintyre E. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood 1996; 87: 2496-2505.
50. Hunger SP, Cleary ML. What significance should we attribute to the detection of MLL fusion transcripts? Blood 1998; 92: 709-711.
51. Uckun FM, Herman-Hatten K, Crotty M-L, Sensel MG, Sather HN, Tuel-Ahlgren L, Sarquis MB, Bostrom B, Nachman JB, Steinherz PG, Gaynon PS, Heerema N. Clinical significance of MLL/AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 1998; 92: 810-821.
52. Trka J, Zuna J, Hrusak O, Micahalova K, Muzikova K, Kalinova M, Stary J. No evidence for MLL/AF4 expression in normal cord blood samples. Blood 1999; 93: 1106-1107.
53. Kim-Rouille MH, MacCregor A Wiedemann LM, Greaves MF, Navarrette C. MLL-AF4 gene fusions in normal newborns. Blood 1999; 93: 1107-1108.
54. Williams DL, Harris A, Williams KJ, Brosius MJ, Lemonds W. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984; 13: 239-257.
55. ISCN (1995). Mitelman F (ed). An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 1995.
56. Hopman AH, Voorter CE, Ramaekers FC. Detection of genomic changes in cancer by in situ hybridization. Mol Bio Rep 1994; 19: 31-44.
57. Pui CH, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, Head DR, Mahmoud HH, Sandlund JT, Furman WL et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994; 12: 909-915.
58. Pui CH, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GH, Evans WE, Crist WM, Krance R. Prognostic factors in acute lymphoid and myeloid leukemias of infants. Leukemia 1996; 10: 952-956.
59. Caligiuri MA, Schichman SA, Strout MP, Mrozek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocation. Cancer Res 1994; 54: 370-373.
60. Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA, Evans G, Young BD. Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood 1994; 84: 3776-3780.
61. Bernard OA, Romana SP, Schichman SA, Mauchauffe M, Jonveaux P, Berger R. Partial duplication of HRX in acute leukemia with trisomy 11. Leukemia 1995; 9: 1487-1489.
62. Kwong YL, Liang R, Chan V, Chan TK. Molecular rearrangement of the MLL gene in adult acute myeloid leukemia without cytogenetic evidence of 11q23 aberration. Cancer Cenet Cytogenet 1996; 86: 13-17.
63. Kwong YL. Partial duplication of the MLL gene in acute myelogenous leukemia without karyotypic aberration. Cancer Genet Cytogenet 1997; 97: 20-24.
64. Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F, Knuutila S, Mrozek K, Oberkircher AR, Marcucci G, De la Chapelle A, Elonen E, Block AW, Rao NP, Herzig GP, Powell BL, Ruutu T, Schiffer CA, Bloomfield CD. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998; 58: 55-59.
65. Schnittger S, Wormann B, Hiddemann W, Griesinger F. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998; 92: 1728-1734.
66. Sanford JP, Sait SNJ, Pan L, Nowak NJ, Gill HJ, LeBeau MM, Diaz MO, Zabel B, Shows TB. Characterization of two 11q23.3-11q24 deletions and mapping of associated anonymous DNA markers. Genes Chromos Cancer 1993; 7: 67-73.
67. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 1993; 81: 3197-3203.
68. Gu Y, Alder H, Nakamura T, Schichman SA, Prasad R, Canaani O, Saito H, Croce CM, Canaani E. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res 1994; 54: 2327-2330.
69. Harbott J, Mancini M, Verellen-Dumoulin Ch, Moorman AV, Seeker-Walker LM. Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. Leukemia 1998; 12: 823-827.
70. Kobayashi H, Espinosa R III, Thirman MJ, Gill HJ, Fernald AA, Diaz MO, Le Beau MM, Rowley JD. Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization. Blood 1993; 82: 547-551.
71. Martineau M, Berger R, Lillington DM, Moorman MV, Secker-Walker LM. The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical study of 30 clinical cases, Leukemia 1998; 12: 788-791.
72. Lillington DM, Young BD, Berger R, Martineau M, Moorman AV, Seeker-Walker LM. The t(10;11)(p12;q23) translocation in acute leukemia: a cytogenetic and clinical study of 20 patients. Leukemia 1998; 12: 801-804.
73. Moorman AV, Hagemeijer A, Charrin C, Rieder H, Secker-Walker LM. The translocations, t(11;19)(q23;p13.1) and t(11;19) (q23;q13.3): a cytogenetic and clinical profile of 53 patients. Leukemia 1998; 12: 805-810.
74. Pui CH, Raimondi SC, Murphy SB, Ribeiro RC, Kalwinsky DK, Dahl GV, Crist WM, Williams DL. An analysis of leukemic cell chromosomal features in infants. Blood 1987; 69: 1289-1293.